Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of sulfonamide-based drugs. It plays a role in creating inhibitors targeting enzymes such as carbonic anhydrase, which are relevant in treating conditions like glaucoma, epilepsy, and certain cancers. Its cyclohexane-carboxylic acid structure provides steric bulk and stability, enhancing selectivity and binding affinity in drug design. Commonly employed in medicinal chemistry for optimizing pharmacokinetic properties and improving metabolic stability in lead compounds.